Multicenter Phase II trial of high-dose imatinib mesylate...

Cancer 2006 Vol. 106; Iss. 9

Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma : Significant toxicity with no clinical efficacy

Ken Wyman, Michael B. Atkins, Victor Prieto, Omar Eton, David F. McDermott, Francie Hubbard, Christine Byrnes, Kathleen Sanders, Jeffrey A. Sosman
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
106
Year:
2006
Language:
english
Pages:
7
DOI:
10.1002/cncr.21834
File:
PDF, 98 KB
english, 2006
Conversion to is in progress
Conversion to is failed